The University of Southampton
University of Southampton Institutional Repository

Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome

Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome
Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome
Abstract Background The gut microbiota contributes to macrophage-mediated inflammation in adipose tissue with consumption of an obesogenic diet, thus driving the development of metabolic syndrome. There is a need to identify and develop interventions that abrogate this condition. The hops-derived prenylated flavonoid xanthohumol (XN) and its semi-synthetic derivative tetrahydroxanthohumol (TXN) attenuate high-fat diet-induced obesity, hepatosteatosis, and metabolic syndrome in C57Bl/6J mice. This coincides with a decrease in pro-inflammatory gene expression in the gut and adipose tissue, together with alterations in the gut microbiota and bile acid composition. Results In this study, we integrated and interrogated multi-omics data from different organs with fecal 16S rRNA sequences and systemic metabolic phenotypic data using a Transkingdom Network Analysis. By incorporating cell type information from single-cell RNA-seq data, we discovered TXN attenuates macrophage inflammatory processes in adipose tissue. TXN treatment also reduced levels of inflammation-inducing microbes, such as Oscillibacter valericigenes, that lead to adverse metabolic phenotypes. Furthermore, in vitro validation in macrophage cell lines and in vivo mouse supplementation showed addition of O. valericigenes supernatant induced the expression of metabolic macrophage signature genes that are downregulated by TXN in vivo. Conclusions Our findings establish an important mechanism by which TXN mitigates adverse phenotypic outcomes of diet-induced obesity and metabolic syndrome. TXN primarily reduces the abundance of pro-inflammatory gut microbes that can otherwise promote macrophage-associated inflammation in white adipose tissue. Video Abstract
figshare
Bruce, A. M.
43149adf-8664-4897-83cc-0aa4032cd5bb
Padiadpu, J.
27885b1e-3601-4159-bfe4-b2ae9a3f6d0f
Morgun, A.
10fce1a1-2936-4561-b06a-5eb3fd55ba00
Newman, N. K.
c0f74db7-a2ab-49b0-97aa-ba0c57e1f3e2
Miranda, C. L.
3cc40d14-2950-4374-b2cc-4ce1b62f5c64
Gurung, M.
1aeae32b-c327-4127-b498-1c8d73123e18
Pederson, J. W.
0ffa8b1d-d103-4c3a-ad7b-a8e908eaed98
Li, Z.
da13d464-ae02-4e81-a5d1-3084eda0e6c7
Wong, C. P.
87cf1998-dc2c-4894-ac14-d3d168989632
Magana, A. A.
9a4cff11-04e9-4a88-8f2d-cb733cfba63c
Sharpton, T. J.
448c0397-94d3-4162-b5d7-2b2cb116495a
Zhang, Y.
61023929-cada-4099-ba6b-6f4cd9c679d4
Gombart, A. F.
e9fe8071-c8d0-456b-9524-7ab2bcb34a44
Bobe, G.
2d877af0-18fb-4f91-8a10-b19fa62e8a99
Maier, C. S.
d6f8d1d5-cd8c-47a5-967b-c3444a8319e6
Brown, K.
fc343b34-8a1a-4bfe-b73e-b089d5a48ba6
Shulzhenko, N.
322b547c-b195-4734-bb21-70edad007ab4
Stevens, J. F.
20d83624-2cba-4703-a0fb-a955319c28ca
Hioki, K. A.
98416e7b-f7aa-4453-8cab-c918910bfc3d
Bruce, A. M.
43149adf-8664-4897-83cc-0aa4032cd5bb
Padiadpu, J.
27885b1e-3601-4159-bfe4-b2ae9a3f6d0f
Morgun, A.
10fce1a1-2936-4561-b06a-5eb3fd55ba00
Newman, N. K.
c0f74db7-a2ab-49b0-97aa-ba0c57e1f3e2
Miranda, C. L.
3cc40d14-2950-4374-b2cc-4ce1b62f5c64
Gurung, M.
1aeae32b-c327-4127-b498-1c8d73123e18
Pederson, J. W.
0ffa8b1d-d103-4c3a-ad7b-a8e908eaed98
Li, Z.
da13d464-ae02-4e81-a5d1-3084eda0e6c7
Wong, C. P.
87cf1998-dc2c-4894-ac14-d3d168989632
Magana, A. A.
9a4cff11-04e9-4a88-8f2d-cb733cfba63c
Sharpton, T. J.
448c0397-94d3-4162-b5d7-2b2cb116495a
Zhang, Y.
61023929-cada-4099-ba6b-6f4cd9c679d4
Gombart, A. F.
e9fe8071-c8d0-456b-9524-7ab2bcb34a44
Bobe, G.
2d877af0-18fb-4f91-8a10-b19fa62e8a99
Maier, C. S.
d6f8d1d5-cd8c-47a5-967b-c3444a8319e6
Brown, K.
fc343b34-8a1a-4bfe-b73e-b089d5a48ba6
Shulzhenko, N.
322b547c-b195-4734-bb21-70edad007ab4
Stevens, J. F.
20d83624-2cba-4703-a0fb-a955319c28ca
Hioki, K. A.
98416e7b-f7aa-4453-8cab-c918910bfc3d

(2023) Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome. figshare doi:10.6084/m9.figshare.c.6847148.v1 [Dataset]

Record type: Dataset

Abstract

Abstract Background The gut microbiota contributes to macrophage-mediated inflammation in adipose tissue with consumption of an obesogenic diet, thus driving the development of metabolic syndrome. There is a need to identify and develop interventions that abrogate this condition. The hops-derived prenylated flavonoid xanthohumol (XN) and its semi-synthetic derivative tetrahydroxanthohumol (TXN) attenuate high-fat diet-induced obesity, hepatosteatosis, and metabolic syndrome in C57Bl/6J mice. This coincides with a decrease in pro-inflammatory gene expression in the gut and adipose tissue, together with alterations in the gut microbiota and bile acid composition. Results In this study, we integrated and interrogated multi-omics data from different organs with fecal 16S rRNA sequences and systemic metabolic phenotypic data using a Transkingdom Network Analysis. By incorporating cell type information from single-cell RNA-seq data, we discovered TXN attenuates macrophage inflammatory processes in adipose tissue. TXN treatment also reduced levels of inflammation-inducing microbes, such as Oscillibacter valericigenes, that lead to adverse metabolic phenotypes. Furthermore, in vitro validation in macrophage cell lines and in vivo mouse supplementation showed addition of O. valericigenes supernatant induced the expression of metabolic macrophage signature genes that are downregulated by TXN in vivo. Conclusions Our findings establish an important mechanism by which TXN mitigates adverse phenotypic outcomes of diet-induced obesity and metabolic syndrome. TXN primarily reduces the abundance of pro-inflammatory gut microbes that can otherwise promote macrophage-associated inflammation in white adipose tissue. Video Abstract

This record has no associated files available for download.

More information

Published date: 22 September 2023

Identifiers

Local EPrints ID: 484986
URI: http://eprints.soton.ac.uk/id/eprint/484986
PURE UUID: 70265cda-71bb-41a9-a6de-44762d1c7927

Catalogue record

Date deposited: 27 Nov 2023 17:52
Last modified: 23 Jan 2024 17:37

Export record

Altmetrics

Contributors

Contributor: A. M. Bruce
Contributor: J. Padiadpu
Contributor: A. Morgun
Contributor: N. K. Newman
Contributor: C. L. Miranda
Contributor: M. Gurung
Contributor: J. W. Pederson
Contributor: Z. Li
Contributor: C. P. Wong
Contributor: A. A. Magana
Contributor: T. J. Sharpton
Contributor: Y. Zhang
Contributor: A. F. Gombart
Contributor: G. Bobe
Contributor: C. S. Maier
Contributor: K. Brown
Contributor: N. Shulzhenko
Contributor: J. F. Stevens
Contributor: K. A. Hioki

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×